First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $171.49 | 52-week high | $183.60 |
| Prev. close | $173.98 | 52-week low | $140.36 |
| Day low | $170.83 | Volume | 29,600 |
| Day high | $173.93 | Avg. volume | 26,160 |
| 50-day MA | $174.61 | Dividend yield | 0.67% |
| 200-day MA | $167.72 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.55% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 1.15B |
| Net Asset Value (NAV) | $173.85 |
| Options? | Yes |
| Total Holdings | 32 |
FBT Top Holdings
| Symbol | Company | % of Total |
| ITCI | Intra-Cellular Therapies Inc. | 4.55% |
| GILD | Gilead Sciences Inc. | 4.3% |
| AMGN | Amgen Inc. | 4.07% |
| ALKS | Alkermes Plc | 4.02% |
| VRTX | Vertex Pharmaceuticals Incorporated | 3.92% |
| HALO | Halozyme Therapeutics Inc. | 3.8% |
| CORT | Corcept Therapeutics Inc. | 3.65% |
| GMAB | Genmab A/S (ADR) | 3.58% |
| BMRN | BioMarin Pharmaceutical Inc. | 3.53% |
FBT Price Returns
| 1-mo | -2.86% |
| 3-mo | -1.11% |
| 6-mo | 2.53% |
| 1-year | 10.69% |
| 3-year | 22.41% |
| 5-year | 45.84% |
| YTD | 3.18% |
| 2024 | 5.88% |
| 2023 | 2.55% |
| 2022 | -4.83% |
| 2021 | -2.26% |
| 2020 | 12.96% |
FBT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||